Accenture and Synopsys jump while Corteva plunges 84% in midday trading

  • Accenture shares surged 18% after fiscal fourth-quarter results exceeded company guidance and analyst estimates.
  • Corteva's remaining business plunged 84% after the Vylor spinoff was formally completed.
  • United Therapeutics gained 6% after a Delaware court ruled Liquidia infringed its patent.

Accenture shares soared 18% after fiscal fourth-quarter revenue and earnings exceeded expectations, while Synopsys jumped more than 8% after outlining growth targets and announcing a partnership with OpenAI. United Therapeutics gained 6% after a Delaware federal court ruled that Liquidia infringed its patent, sending Liquidia down 15%. Constellation Energy rose nearly 3% on a 20-year Amazon agreement tied to expanded generation at a Maryland nuclear plant, and McKesson climbed 4% after reaffirming fiscal 2027 earnings guidance and extending its CVS Health distribution partnership through June 2032. McCormick fell more than 2% despite beating quarterly estimates as it remains in the process of being acquired by Unilever, whose shares also dropped more than 2%. Sigma Lithium slid 16% after suspending mining and industrial production in Brazil, while Acuity Brands declined nearly 4% on weaker-than-expected forward guidance. BJ's Restaurants rose about 5% after a Mizuho upgrade, Vicor surged almost 10% after raising its revenue growth outlook, and Corteva's remaining business plunged 84% following the formal spinoff of its Vylor seed and genetic business.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.